Medicare Enrolled
Dr. John Dalena, M.D.
Optician · Florham Park, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dalena from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dalena?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dalena
Dr. John Dalena is an optician specialist in Florham Park, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dalena performed 2,272 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dalena received a total of $7,325 from 31 pharmaceutical and/or device companies across 509 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dalena is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 30% volume in NJ
$7,325 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,272
Medicare services
Top 30% in NJ for optician
Not available
Unique patients (not deduplicated)
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
489 | $75 | $188 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
269 | $226 | $2,579 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
248 | $108 | $274 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
239 | $88 | $2,208 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
108 | $49 | $116 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
107 | $151 | $1,920 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
100 | $8 | $15 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
88 | $146 | $2,494 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
79 | $198 | $1,922 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
75 | $201 | $1,918 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
73 | $92 | $274 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
62 | $10 | $40 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
53 | $8 | $32 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $135 | $412 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
34 | $5 | $22 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
28 | $9 | $38 |
| Measurement of tissue transglutaminase | 28 | $11 | $35 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
27 | $3 | $12 |
| Stool calprotectin level test A laboratory test that measures the level of calprotectin protein in a stool sample. This test is used to evaluate inflammation in the intestines. |
26 | $18 | $81 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
23 | $16 | $69 |
| Clostridium difficile nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Clostridium difficile bacteria. This method identifies the organism's genetic material to diagnose infection. |
23 | $35 | $49 |
| Pancreatic elastase stool test A laboratory test that measures the level of pancreatic elastase enzyme in a stool sample to assess pancreatic function. |
17 | $23 | $69 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
16 | $13 | $56 |
| Iron level test | 12 | $6 | $27 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
11 | $4 | $17 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,325
Total received (2018-2024)
Avg $1,046/year across 7 years
Top 13% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
509
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,392
2023
$1,175
2022
$948
2021
$903
2020
$714
2019
$1,151
2018
$1,043
Payments by company (2024)
ABBVIE INC.
$299
Lilly USA, LLC
$184
Janssen Biotech, Inc.
$171
Celgene Corporation
$132
Braintree Laboratories, Inc.
$126
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$112
QOL Medical, LLC
$96
PFIZER INC.
$90
Intercept Pharmaceuticals, Inc.
$66
Takeda Pharmaceuticals U.S.A., Inc.
$51
Phathom Pharmaceuticals, Inc.
$31
Regeneron Healthcare Solutions, Inc.
$18
Celltrion USA Inc.
$16
Top 3 companies account for 47.0% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,393
Janssen Biotech, Inc.
$1,035
AbbVie Inc.
$656
Celgene Corporation
$576
ABBVIE INC.
$569
Ironwood Pharmaceuticals, Inc
$525
Takeda Pharmaceuticals U.S.A., Inc.
$388
AbbVie, Inc.
$332
PFIZER INC.
$317
Lilly USA, LLC
$218
Ferring Pharmaceuticals Inc.
$217
Merck Sharp & Dohme Corporation
$165
Braintree Laboratories, Inc.
$156
QOL Medical, LLC
$109
UCB, Inc.
$98
Intercept Pharmaceuticals, Inc.
$81
Synergy Pharmaceuticals Inc
$79
Regeneron Healthcare Solutions, Inc.
$68
IRONWOOD PHARMACEUTICALS, INC
$60
Evoke Pharma, Inc.
$47
EVOKE PHARMA, INC.
$34
Phathom Pharmaceuticals, Inc.
$31
Nestle HealthCare Nutrition Inc.
$30
Shire North American Group Inc
$29
Allergan Inc.
$22
GENZYME CORPORATION
$17
Celltrion USA Inc.
$16
RedHill Biopharma Inc.
$15
Daiichi Sankyo Inc.
$14
Gilead Sciences, Inc.
$14
INTERCEPT PHARMACEUTICALS, INC.
$13
Top 3 companies account for 42.1% of all-time payments
Associated products mentioned in payments ›
Amitiza · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · Entyvio · GATTEX · GIMOTI · HUMIRA · Humira · LINZESS · Linzess · MOTOFEN · Motegrity · Movantik · NOXAFIL · OCALIVA · OMVOH · REBYOTA · REMICADE · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUTAB · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · UCERIS TABLETS · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
8,489
County median income
$134,929
Nearest hospital to ZIP centroid (approximate)
COOPERMAN BARNABAS MEDICAL CENTER
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dalena is a clinical cardiology specialist, with above-average Medicare volume (top 30% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dalena experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Dalena performed 489 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dalena receive payments from pharmaceutical companies?
Yes. Dr. Dalena received a total of $7,325 from 31 companies across 509 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dalena's costs compare to other opticians in Florham Park?
Dr. Dalena's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dalena) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Florham Park
Browse opticians in Florham Park ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology